Cargando…
Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study
AIMS/HYPOTHESIS: Serum sex hormone-binding globulin (SHBG) has been proposed to act as a hepatokine that contributes to the extrahepatic complications observed in non-alcoholic fatty liver disease (NAFLD). However, it remains uncertain whether serum SHBG mediates the association between intrahepatic...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729158/ https://www.ncbi.nlm.nih.gov/pubmed/36114428 http://dx.doi.org/10.1007/s00125-022-05790-7 |
_version_ | 1784845424074424320 |
---|---|
author | Simons, Pomme I. H. G. Valkenburg, Olivier van de Waarenburg, Marjo P. H. van Greevenbroek, Marleen M. J. Kooi, M. Eline Jansen, Jacobus F. A. Schalkwijk, Casper G. Stehouwer, Coen D. A. Brouwers, Martijn C. G. J. |
author_facet | Simons, Pomme I. H. G. Valkenburg, Olivier van de Waarenburg, Marjo P. H. van Greevenbroek, Marleen M. J. Kooi, M. Eline Jansen, Jacobus F. A. Schalkwijk, Casper G. Stehouwer, Coen D. A. Brouwers, Martijn C. G. J. |
author_sort | Simons, Pomme I. H. G. |
collection | PubMed |
description | AIMS/HYPOTHESIS: Serum sex hormone-binding globulin (SHBG) has been proposed to act as a hepatokine that contributes to the extrahepatic complications observed in non-alcoholic fatty liver disease (NAFLD). However, it remains uncertain whether serum SHBG mediates the association between intrahepatic lipids (IHL) and type 2 diabetes. Therefore, we studied whether, and to what extent, serum SHBG mediates the association between IHL content and type 2 diabetes. METHODS: We used cross-sectional data from the Maastricht Study (n=1554), a population-based cohort study with oversampling of individuals with type 2 diabetes. Type 2 diabetes status was assessed by oral glucose tolerance test, and IHL content was measured using 3T Dixon MRI. Mediation analyses were performed to assess the role of serum SHBG in mediating the association between IHL content and type 2 diabetes. RESULTS: IHL content was significantly associated with type 2 diabetes in women and men (OR 1.08 [95% CI 1.04, 1.14] and OR 1.12 [95% CI 1.08, 1.17], respectively). Serum SHBG significantly mediated the association between IHL content and type 2 diabetes. The contribution of serum SHBG was higher in women (OR 1.04 [95% CI 1.02, 1.07]; proportion mediated 50.9% [95% CI 26.7, 81.3]) than in men (OR 1.02 [95% CI 1.01, 1.03]; proportion mediated 17.2% [95% CI 9.6, 27.6]). Repeat analyses with proxies of type 2 diabetes and adjustment for covariates did not substantially affect the results. CONCLUSIONS/INTERPRETATION: In this large-scale population-based cohort study, serum SHBG was found to be a mediator of the association between IHL content and type 2 diabetes. These findings extend our understanding of the potential mechanisms by which NAFLD is a risk factor for type 2 diabetes, and further elaborate on the role of SHBG as a hepatokine. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-022-05790-7 |
format | Online Article Text |
id | pubmed-9729158 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-97291582022-12-09 Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study Simons, Pomme I. H. G. Valkenburg, Olivier van de Waarenburg, Marjo P. H. van Greevenbroek, Marleen M. J. Kooi, M. Eline Jansen, Jacobus F. A. Schalkwijk, Casper G. Stehouwer, Coen D. A. Brouwers, Martijn C. G. J. Diabetologia Article AIMS/HYPOTHESIS: Serum sex hormone-binding globulin (SHBG) has been proposed to act as a hepatokine that contributes to the extrahepatic complications observed in non-alcoholic fatty liver disease (NAFLD). However, it remains uncertain whether serum SHBG mediates the association between intrahepatic lipids (IHL) and type 2 diabetes. Therefore, we studied whether, and to what extent, serum SHBG mediates the association between IHL content and type 2 diabetes. METHODS: We used cross-sectional data from the Maastricht Study (n=1554), a population-based cohort study with oversampling of individuals with type 2 diabetes. Type 2 diabetes status was assessed by oral glucose tolerance test, and IHL content was measured using 3T Dixon MRI. Mediation analyses were performed to assess the role of serum SHBG in mediating the association between IHL content and type 2 diabetes. RESULTS: IHL content was significantly associated with type 2 diabetes in women and men (OR 1.08 [95% CI 1.04, 1.14] and OR 1.12 [95% CI 1.08, 1.17], respectively). Serum SHBG significantly mediated the association between IHL content and type 2 diabetes. The contribution of serum SHBG was higher in women (OR 1.04 [95% CI 1.02, 1.07]; proportion mediated 50.9% [95% CI 26.7, 81.3]) than in men (OR 1.02 [95% CI 1.01, 1.03]; proportion mediated 17.2% [95% CI 9.6, 27.6]). Repeat analyses with proxies of type 2 diabetes and adjustment for covariates did not substantially affect the results. CONCLUSIONS/INTERPRETATION: In this large-scale population-based cohort study, serum SHBG was found to be a mediator of the association between IHL content and type 2 diabetes. These findings extend our understanding of the potential mechanisms by which NAFLD is a risk factor for type 2 diabetes, and further elaborate on the role of SHBG as a hepatokine. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains peer-reviewed but unedited supplementary material available at 10.1007/s00125-022-05790-7 Springer Berlin Heidelberg 2022-09-17 2023 /pmc/articles/PMC9729158/ /pubmed/36114428 http://dx.doi.org/10.1007/s00125-022-05790-7 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Article Simons, Pomme I. H. G. Valkenburg, Olivier van de Waarenburg, Marjo P. H. van Greevenbroek, Marleen M. J. Kooi, M. Eline Jansen, Jacobus F. A. Schalkwijk, Casper G. Stehouwer, Coen D. A. Brouwers, Martijn C. G. J. Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study |
title | Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study |
title_full | Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study |
title_fullStr | Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study |
title_full_unstemmed | Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study |
title_short | Serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the Maastricht Study |
title_sort | serum sex hormone-binding globulin is a mediator of the association between intrahepatic lipid content and type 2 diabetes: the maastricht study |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9729158/ https://www.ncbi.nlm.nih.gov/pubmed/36114428 http://dx.doi.org/10.1007/s00125-022-05790-7 |
work_keys_str_mv | AT simonspommeihg serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy AT valkenburgolivier serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy AT vandewaarenburgmarjoph serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy AT vangreevenbroekmarleenmj serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy AT kooimeline serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy AT jansenjacobusfa serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy AT schalkwijkcasperg serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy AT stehouwercoenda serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy AT brouwersmartijncgj serumsexhormonebindingglobulinisamediatoroftheassociationbetweenintrahepaticlipidcontentandtype2diabetesthemaastrichtstudy |